Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Economic evaluation of aclasta (R) (zoledronic...
Conference

Economic evaluation of aclasta (R) (zoledronic acid 5 mg) versus actonel (R) (risedronate) in treatment of Paget's disease

Authors

Mittmann N; Isogai PK; Adachi JD; Kindundu CM; Barbeau M

Volume

17

Pagination

pp. S189-S189

Publisher

SPRINGER LONDON LTD

Publication Date

May 1, 2006

Name of conference

7th International Symposium on Osteoporosis

Conference place

Washington, DC

Conference start date

April 18, 2007

Conference end date

April 22, 2007

Conference proceedings

OSTEOPOROSIS INTERNATIONAL

ISSN

0937-941X

Labels